Literature DB >> 32717271

Ulcerative colitis: Gut microbiota, immunopathogenesis and application of natural products in animal models.

Roberto de Paula do Nascimento1, Ana Paula da Fonseca Machado1, Julio Galvez2, Cinthia Baú Betim Cazarin3, Mario Roberto Maróstica Junior4.   

Abstract

Ulcerative colitis (UC) is an inflammatory bowel disease with increasing incidence in the world, especially in developing countries. Although knowledge of its pathogenesis has progressed over the last years, some details require clarification. Studies have highlighted the role of microbial dysbiosis and immune dysfunction as essential factors that may initiate the typical high-grade inflammatory outcome. In order to better understand the immunopathophysiological aspects of UC, experimental murine models are valuable tools. Some of the most commonly used chemicals to induce colitis are trinitrobenzene sulfonic acid, oxazolone and dextran sodium sulfate. These may also be used to investigate new ways of preventing or treating UC and therefore improving targeting in human studies. The use of functional foods or bioactive compounds from plants may constitute an innovative direction towards the future of alternative medicine. Considering the above, this review focused on updated information regarding the 1. gut microbiota and immunopathogenesis of UC; 2. the most utilized animal models of the disease and their relevance; and 3. experimental application of natural products, not yet tested in clinical trials.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bioactive compounds; Dextran sodium sulfate; Functional foods; Inflammation; Inflammatory bowel diseases; Microbiota; Natural products; Oxazolone; Trinitrobenzene sulfonic acid

Mesh:

Substances:

Year:  2020        PMID: 32717271     DOI: 10.1016/j.lfs.2020.118129

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

1.  Aromatic-turmerone ameliorates DSS-induced ulcerative colitis via modulating gut microbiota in mice.

Authors:  Chunlian Li; Weicheng Zhang; Xianyi Wu; Qiuyang Cai; Zekai Tan; Zhengyi Hong; Shiyuan Huang; Yanghe Yuan; Lewen Yao; Lanyue Zhang
Journal:  Inflammopharmacology       Date:  2022-07-06       Impact factor: 5.093

2.  Prevention of Ulcerative Colitis in Mice by Sweet Tea (Lithocarpus litseifolius) via the Regulation of Gut Microbiota and Butyric-Acid-Mediated Anti-Inflammatory Signaling.

Authors:  Xiao-Qin He; Dan Liu; Hong-Yan Liu; Ding-Tao Wu; Hua-Bin Li; Xin-Shang Zhang; Ren-You Gan
Journal:  Nutrients       Date:  2022-05-26       Impact factor: 6.706

Review 3.  The Communication Between Intestinal Microbiota and Ulcerative Colitis: An Exploration of Pathogenesis, Animal Models, and Potential Therapeutic Strategies.

Authors:  Yu Hu; Zhen Ye; Mingquan Wu; Yingqi She; Linzhen Li; Yujie Xu; Kaihua Qin; Zhipeng Hu; Maoyi Yang; Fating Lu; Qiaobo Ye
Journal:  Front Med (Lausanne)       Date:  2021-12-13

4.  Chemoprevention with a tea from hawthorn (Crataegus oxyacantha) leaves and flowers attenuates colitis in rats by reducing inflammation and oxidative stress.

Authors:  Roberto de Paula do Nascimento; Ana Paula da Fonseca Machado; Verena Silva Lima; Amanda Maria Tomazini Munhoz Moya; Lívia Mateus Reguengo; Stanislau Bogusz Junior; Raquel Franco Leal; Phu Cao-Ngoc; Jean Christophe Rossi; Laurent Leclercq; Hervé Cottet; Cinthia Baú Betim Cazarin; Mario Roberto Marostica Junior
Journal:  Food Chem X       Date:  2021-10-07

5.  Yiyi Fuzi Baijiang Decoction Alleviates Ulcerative Colitis Partly by Regulating TLR4-Mediated PI3K/Akt and NF-κB Pathways.

Authors:  Liping Chen; Chunyu Zhang; Jingjing Cao; Ge Bei; Xiaoyu Wang; Zhiwei Miao
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-15       Impact factor: 2.629

Review 6.  Natural Products Modulate Cell Apoptosis: A Promising Way for the Treatment of Ulcerative Colitis.

Authors:  Chenhao Liu; Yiwei Zeng; Yulong Wen; Xinggui Huang; Yi Liu
Journal:  Front Pharmacol       Date:  2022-01-31       Impact factor: 5.810

7.  Substantial Intestinal Microbiota Differences Between Patients With Ulcerative Colitis From Ghana and Denmark.

Authors:  Hengameh Chloé Mirsepasi-Lauridsen; Katleen Vranckx; Henrik Vedel Nielsen; Lee O'Brien Andersen; Timothy Archampong; Karen Angeliki Krogfelt; Andreas Munk Petersen
Journal:  Front Cell Infect Microbiol       Date:  2022-03-03       Impact factor: 5.293

8.  Atractylenolide III Improves Mitochondrial Function and Protects Against Ulcerative Colitis by Activating AMPK/SIRT1/PGC-1α.

Authors:  Jieru Han; Wenhao Li; Guangyu Shi; Yunlei Huang; Xutao Sun; Na Sun; Deyou Jiang
Journal:  Mediators Inflamm       Date:  2022-04-08       Impact factor: 4.529

Review 9.  Efficacy and Safety of Probiotics Combined With Traditional Chinese Medicine for Ulcerative Colitis: A Systematic Review and Meta-Analysis.

Authors:  Yu Hu; Zhen Ye; Yingqi She; Linzhen Li; Mingquan Wu; Kaihua Qin; Yuzheng Li; Haiqing He; Zhipeng Hu; Maoyi Yang; Fating Lu; Qiaobo Ye
Journal:  Front Pharmacol       Date:  2022-03-07       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.